RECRUITING

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Official Title

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

Quick Facts

Study Start:2022-10-31
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05407168

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * AIM 1: Suspected lung cancer
  2. * AIM 1: English fluency
  3. * AIM 1: \> 6-month life expectancy
  4. * AIM 1: Score of ≥ 3 on the cognitive impairment screener
  5. * AIM 2 PARTICIPANTS: Participation in Aim 1
  6. * AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Donald R Sullivan, MD, MA, MCR
PRINCIPAL_INVESTIGATOR
OHSU Knight Cancer Institute

Study Locations (Sites)

Hillsboro Medical Center
Hillsboro, Oregon, 97123
United States
Adventist Health Portland
Portland, Oregon, 97216
United States
OHSU Knight Cancer Institute
Portland, Oregon, 97239
United States
Portland VA Medical Center
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: OHSU Knight Cancer Institute

  • Donald R Sullivan, MD, MA, MCR, PRINCIPAL_INVESTIGATOR, OHSU Knight Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-31
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2022-10-31
Study Completion Date2027-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Carcinoma